[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-zoetis-stock-why-12-pipeline-blockbusters-could-support-a-40-upside-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":266,"suggestedPosts":343},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95669,"L'action Zoetis : Pourquoi 12 produits phares du pipeline pourraient soutenir une hausse de 40 % ?","2026-03-04T12:00:00","2026-03-04T03:42:20","\u003Cp>Zoetis vient d'acquérir l'activité génomique de Neogen, mais le véritable catalyseur arrivera plus tard, en 2026, lorsque CYTOPOINT à action prolongée demandera l'autorisation de mise sur le marché américain, une décision qui pourrait redéfinir l'ensemble de la situation concurrentielle de ZTS.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-zoetis-stock\">Principales statistiques pour l'action Zoetis\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance de la semaine écoulée : \u003C\u002Fstrong>+1.8%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 115,3 $ à 177\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Cours actuel : \u003C\u002Fstrong> 125,9\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>La plupart des investisseurs ne savent jamais si un titre est réellement sous-évalué ou surévalué. Les outils d'évaluation de TIKR, de qualité professionnelle, vous donnent une réponse claire et étayée par des données sur plus de 60 000 actions, et ce gratuitement.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'action Zoetis\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=215548781&tid=226099795&ref=tikrblog\">(ZTS\u003C\u002Fa>) se négocie à 125,93 $, soit près de 29 % en dessous de son plus haut de 52 semaines (177,00 $), ce qui sous-estime une société qui vient de dépasser de 27 millions de dollars les estimations de chiffre d'affaires du quatrième trimestre tout en acquérant l'activité génomique de Neogen le 2 mars.\u003C\u002Fp>\n\n\n\n\u003Cp>L'analyste Daniel Clark de Leerink Partners a souligné que les franchises Simparica, dermatologie et douleur OA ont été plus faibles que prévu, mais Zoetis a tout de même délivré un BPA ajusté de 1,48 $ au quatrième trimestre, contre une estimation de 1,40 $.\u003C\u002Fp>\n\n\n\n\u003Cp>En dessous de l'annonce de l'échec, la franchise Simparica a généré à elle seule 1,5 milliard de dollars de revenus en 2025, avec une croissance opérationnelle de 12%, et Simparica Trio a franchi pour la première fois le cap du milliard de dollars de ventes annuelles aux Etats-Unis.\u003C\u002Fp>\n\n\n\n\u003Cp>Kristin Peck, Chief Executive Officer, a déclaré lors de la conférence téléphonique sur les résultats du quatrième trimestre qu'\"il ne s'agit pas d'un déclin de la demande sous-jacente de soins, mais plutôt d'une plus grande sensibilité aux prix et d'un resserrement des budgets des ménages\", ce qui est d'autant plus pertinent que le Numelvi de Merck a reçu l'approbation de la FDA américaine le 25 février, intensifiant ainsi la concurrence dans le domaine de la dermatologie.\u003C\u002Fp>\n\n\n\n\u003Cp>Avec l'approbation de CYTOPOINT à action prolongée attendue fin 2026, le lancement de Lenivia dans l'UE et au Canada au premier semestre 2026, et 12 produits phares potentiels en cours de développement, Zoetis construit un pipeline qui étend son avance sur la concurrence bien au-delà de la pression actuelle exercée par les franchises.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez le moment exact où Wall Street revalorise un titre avant que le reste du marché ne le fasse - suivez les changements de notation des analystes en temps réel avec TIKR gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-wall-street-s-take-on-zts-stock\">\u003Cstrong>Le point de vue de Wall Street sur l'action ZTS\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'acquisition de Neogen genomics le 2 mars pour 160 millions de dollars étend directement les capacités de Zoetis en matière de santé animale de précision, renforçant la croissance de 4,7 % du chiffre d'affaires que les analystes du consensus prévoient déjà pour 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>Fondamentalement, le chiffre d'affaires passe de 9,5 milliards de dollars en 2025 à 9,9 milliards de dollars en 2026, tandis que le BPA normalisé augmente de 9,6 % pour atteindre 7,0 dollars, signe d'une entreprise qui se stabilise après une année mouvementée.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"834\" height=\"562\" data-public-id=\"images\u002Fimage-67_9567165007\u002Fimage-67_9567165007.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_834,h_562,c_scale\u002Ff_webp,q_auto\u002Fv1772595097\u002Fimages\u002Fimage-67_9567165007\u002Fimage-67_9567165007.png?_i=AA\" alt=\"zoetis stock\" class=\"wp-post-95669 wp-image-95671\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772595097\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772595097\u002Fimages\u002Fimage-67_9567165007\u002Fimage-67_9567165007.png?_i=AA 834w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_202,c_scale\u002Ff_webp,q_auto\u002Fv1772595097\u002Fimages\u002Fimage-67_9567165007\u002Fimage-67_9567165007.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_518,c_scale\u002Ff_webp,q_auto\u002Fv1772595097\u002Fimages\u002Fimage-67_9567165007\u002Fimage-67_9567165007.png?_i=AA 768w\" sizes=\"auto, (max-width: 834px) 100vw, 834px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Cible des analystes pour l'action ZTS \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Wall Street indique actuellement 7 achats, 4 surperformances, et 9 attentes par rapport à un objectif de prix moyen de 151,0 $, ce qui implique une hausse de 19,9 % par rapport à 125,9 $, bien que le nombre croissant d'attentes reflète la lassitude concernant la faiblesse des animaux de compagnie aux États-Unis.\u003C\u002Fp>\n\n\n\n\u003Cp>La fourchette cible des analystes s'étend de 130,0 $ au plus bas à 190,0 $ au plus haut, le scénario à la hausse reposant sur l'approbation de CYTOPOINT à action prolongée attendue fin 2026 et le scénario à la baisse reflétant le déclin soutenu de Librela aux États-Unis après une chute de 32 % au 4ème trimestre.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-does-the-valuation-model-say\">\u003Cstrong>Que dit le modèle d'évaluation ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA\" alt=\"zoetis stock\" class=\"wp-post-95669 wp-image-95672\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772595162\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1772595162\u002Fimages\u002FZTS_valuation_model-2_956728b81c\u002FZTS_valuation_model-2_956728b81c.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Résultats du modèle d'évaluation de l'action ZTS \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le modèle d'évaluation TIKR vise 178,4 dollars d'ici au 31 décembre 2030, soit un rendement total de 41,7 % et un TRI annuel de 7,5 % par rapport aux 125,9 dollars d'aujourd'hui. Cet écart existe malgré une entreprise générant 4,2 milliards de dollars d'EBITDA en 2025 avec des marges de 44,8 %.\u003C\u002Fp>\n\n\n\n\u003Cp>Le marché considère ZTS comme une histoire de dermatologie en déclin, ignorant que Simparica Trio a franchi le milliard de dollars de ventes annuelles aux États-Unis tandis que le bétail a enregistré une croissance opérationnelle organique de 8 % en 2025.\u003C\u002Fp>\n\n\n\n\u003Cp>Les marges EBITDA se sont maintenues à 44,8 % en 2025 malgré la pression concurrentielle et la faiblesse des consommateurs, un niveau de rentabilité structurelle que le prix actuel ne reflète pas.\u003C\u002Fp>\n\n\n\n\u003Cp>Parallèlement, le directeur financier Wetteny Joseph a déclaré lors du Bank of America Animal Health Summit le 26 février que Zoetis voyait \"une déconnexion entre cela et la valeur que nous avons aujourd'hui\", ce qui indique que la direction est convaincue que le prix de l'action est mal évalué.\u003C\u002Fp>\n\n\n\n\u003Cp>Cependant, la baisse de 32 % des ventes de Librela aux États-Unis au quatrième trimestre reste la plus grande menace ; si cette faiblesse se propage à la franchise plus large de la douleur OA, la thèse de la réaccélération du pipeline s'effondre complètement.\u003C\u002Fp>\n\n\n\n\u003Cp>L'approbation de CYTOPOINT, un médicament à action prolongée, attendue aux États-Unis fin 2026, sera le signal le plus clair de la capacité de Zoetis à compenser la concurrence dans le domaine de la dermatologie grâce à un portefeuille de produits de nouvelle génération.\u003C\u002Fp>\n\n\n\n\u003Cp>ZTS est sous-évalué à 125,9 dollars par rapport à son objectif de 178,4 dollars, et le délai d'approbation de CYTOPOINT est la seule variable qui déterminera si cet écart se comblera.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Les meilleures idées de Wall Street ne restent pas cachées longtemps. Avec TIKR, vous pouvez suivre gratuitement les mises à jour des analystes, les résultats supérieurs aux attentes et les surprises en matière de revenus pour des milliers d'actions →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-zoetis-inc\">\u003Cstrong>Devriez-vous investir dans Zoetis Inc.\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est d'examiner les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes données financières de qualité institutionnelle que celles utilisées par les analystes professionnels pour répondre à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>Sélectionnez l'action ZTS et vous verrez des années de données financières historiques, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples d'évaluation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez créer une liste de surveillance gratuite pour suivre Zoetis Inc. en même temps que toutes les autres actions qui vous intéressent. Aucune carte de crédit n'est requise. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Accédez gratuitement à des outils professionnels pour analyser l'action ZTS sur TIKR →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",783,"fr","\u002Fblog\u002Fzoetis-stock-why-12-pipeline-blockbusters-could-support-a-40-upside","zoetis-stock-why-12-pipeline-blockbusters-could-support-a-40-upside","images\u002FFEATURED-IMAGE-MAKER-396\u002FFEATURED-IMAGE-MAKER-396","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772595394\u002Fimages\u002FFEATURED-IMAGE-MAKER-396\u002FFEATURED-IMAGE-MAKER-396.png?_i=AA",{"altText":237,"imageCredit":238},"Zoetis Stock: Why 12 Pipeline Blockbusters Could Support a 40% Upside","TIKR",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Gian Estrada","giantikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Zoetis just acquired Neogen’s genomics business, but the real catalyst arrives later in 2026 when CYTOPOINT long-acting seeks U.S. approval, a decision that could reframe the entire competitive narrative for ZTS.",{"title":237,"description":260,"twitterTitle":237,"twitterDescription":260,"author":240,"articlePublisher":261,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":262,"twitterData1":263,"ogTitle":237,"ogDescription":260,"ogUrl":232,"ogImage":235,"ogImageWidth":264,"ogImageHeight":265,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Zoetis just acquired Neogen’s genomics business, but the real catalyst arrives later in 2026 when CYTOPOINT long-acting seeks U.S. approval, a decision that could reframe the entire competitive narrative for ZTS.","TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[267,284,299,314,329],{"id":255,"title":268,"date":269,"excerpt":270,"wordCount":271,"uri":272,"slug":273,"cloudinaryAssetId":274,"featuredImageOriginalUrl":275,"featuredImageMetadata":276,"author":277,"categories":281,"relatedPosts":283},"L'action Workday bondit de 7,2 % après la chute. Les analystes voient une juste valeur de 186 $.","2026-03-04 11:50:00","Voici pourquoi l'action Workday a bondi après une chute brutale des résultats liée à des prévisions de revenus d'abonnement plus faibles.",731,"\u002Fblog\u002Fworkday-stock-jumps-7-2-after-selloff-analysts-see-186-fair-value","workday-stock-jumps-7-2-after-selloff-analysts-see-186-fair-value","images\u002FWDAY-stock_957733ada4\u002FWDAY-stock_957733ada4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772623812\u002Fimages\u002FWDAY-stock_957733ada4\u002FWDAY-stock_957733ada4.png?_i=AA",{"altText":268},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":280},"Rexielyn Diaz","rexietikr",[],[282],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":285,"date":286,"excerpt":287,"wordCount":288,"uri":289,"slug":290,"cloudinaryAssetId":291,"featuredImageOriginalUrl":292,"featuredImageMetadata":293,"author":294,"categories":296,"relatedPosts":298},"L'action Pinterest bondit de 9 % après l'investissement d'Elliott et le rachat de 2 milliards de dollars. Voici ce que cela signifie pour les investisseurs","2026-03-04 11:30:00","Voici pourquoi l'action Pinterest a bondi après un investissement d'un milliard de dollars de la part d'Elliott et l'annonce d'un rachat d'actions de 2 milliards de dollars.",818,"\u002Fblog\u002Fpinterest-stock-jumps-9-after-elliott-investment-and-2b-buyback-heres-what-it-means-for-investors","pinterest-stock-jumps-9-after-elliott-investment-and-2b-buyback-heres-what-it-means-for-investors","images\u002FPINS-stock_957678c607\u002FPINS-stock_957678c607","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772623140\u002Fimages\u002FPINS-stock_957678c607\u002FPINS-stock_957678c607.png?_i=AA",{"altText":285},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":295},[],[297],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":300,"date":301,"excerpt":302,"wordCount":303,"uri":304,"slug":305,"cloudinaryAssetId":306,"featuredImageOriginalUrl":307,"featuredImageMetadata":308,"author":309,"categories":311,"relatedPosts":313},"L'action Select Medical bondit de 8 % après une offre de rachat à 16,50 $. Voici ce que cela signifie","2026-03-04 11:10:00","Voici pourquoi l'action Select Medical a bondi après une proposition de rachat à 16,50 dollars par action et des bénéfices supérieurs aux prévisions.",730,"\u002Fblog\u002Fselect-medical-stock-jumps-8-after-16-50-buyout-offer-heres-what-the-deal-means","select-medical-stock-jumps-8-after-16-50-buyout-offer-heres-what-the-deal-means","images\u002FSEM-stock\u002FSEM-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772621483\u002Fimages\u002FSEM-stock\u002FSEM-stock.png?_i=AA",{"altText":300},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":310},[],[312],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":315,"date":316,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":326,"relatedPosts":328},"Voici pourquoi l'action Regeneron pourrait générer des rendements supérieurs de 60 %.","2026-03-04 11:00:00","Le Dupixent vient de franchir la barre des 17,8 milliards de dollars de ventes annuelles pour 1,4 million de patients, et avec une neuvième approbation de la FDA maintenant confirmée, les analystes voient 13,6 % de hausse supplémentaire avant que REGN n'atteigne son objectif de prix moyen.",792,"\u002Fblog\u002Fheres-why-regeneron-stock-could-deliver-60-upside-returns","heres-why-regeneron-stock-could-deliver-60-upside-returns","images\u002FFEATURED-IMAGE-MAKER-395\u002FFEATURED-IMAGE-MAKER-395","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772594266\u002Fimages\u002FFEATURED-IMAGE-MAKER-395\u002FFEATURED-IMAGE-MAKER-395.png?_i=AA",{"altText":315},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":325},[],[327],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":330,"date":316,"excerpt":331,"wordCount":332,"uri":333,"slug":334,"cloudinaryAssetId":335,"featuredImageOriginalUrl":336,"featuredImageMetadata":337,"author":338,"categories":340,"relatedPosts":342},"L'action Intapp a bondi de 12 % après des partenariats dans le domaine de l'IA et des bénéfices solides. Les analystes voient une hausse de 68 % à 44 $.","Voici pourquoi l'action Intapp a bondi après de nouveaux partenariats dans le domaine de l'IA, de solides bénéfices et un modèle d'évaluation indiquant une valeur de 44 dollars par action.",789,"\u002Fblog\u002Fintapp-stock-jumped-12-after-ai-partnerships-and-strong-earnings-analysts-see-68-upside-to-44","intapp-stock-jumped-12-after-ai-partnerships-and-strong-earnings-analysts-see-68-upside-to-44","images\u002FINTA-stock-1\u002FINTA-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772621136\u002Fimages\u002FINTA-stock-1\u002FINTA-stock-1.png?_i=AA",{"altText":330},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":339},[],[341],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[344,365,380,395,410,428,440,455,469,484],{"id":255,"title":345,"date":346,"excerpt":347,"wordCount":348,"uri":349,"slug":350,"cloudinaryAssetId":351,"featuredImageOriginalUrl":352,"featuredImageMetadata":353,"author":355,"categories":359,"relatedPosts":364},"L'action Albemarle est en tête des pertes du S&P 500, le producteur de lithium chutant de 8 %.","2026-03-04 10:58:00","Les actions d'Albemarle chutent de 8 % en raison de la chute de 13 % des prix du lithium en Chine. La faiblesse des ventes de VE de BYD et les tensions au Moyen-Orient assombrissent les perspectives de la demande pour le producteur.",596,"\u002Fblog\u002Falbemarle-nyse-stock-leads-sp-500-losses-as-lithium-producer-sinks-8","albemarle-nyse-stock-leads-sp-500-losses-as-lithium-producer-sinks-8","images\u002FALB-stock\u002FALB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772620530\u002Fimages\u002FALB-stock\u002FALB-stock.png?_i=AA",{"altText":354},"L'action Albemarle est en tête des pertes du S&P 500, le producteur de lithium chutant de 8 %.",{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":358},"Aditya Raghunath","adityatikr",[],[360],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":366,"date":367,"excerpt":368,"wordCount":369,"uri":370,"slug":371,"cloudinaryAssetId":372,"featuredImageOriginalUrl":373,"featuredImageMetadata":374,"author":375,"categories":377,"relatedPosts":379},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":366},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":376},[],[378],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":381,"date":382,"excerpt":383,"wordCount":384,"uri":385,"slug":386,"cloudinaryAssetId":387,"featuredImageOriginalUrl":388,"featuredImageMetadata":389,"author":390,"categories":392,"relatedPosts":394},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":381},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":391},[],[393],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":396,"date":397,"excerpt":398,"wordCount":399,"uri":400,"slug":401,"cloudinaryAssetId":402,"featuredImageOriginalUrl":403,"featuredImageMetadata":404,"author":405,"categories":407,"relatedPosts":409},"Le financement massif d'OpenAI déclenche la chute des actions d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":396},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":406},[],[408],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":411,"date":412,"excerpt":413,"wordCount":414,"uri":415,"slug":416,"cloudinaryAssetId":417,"featuredImageOriginalUrl":418,"featuredImageMetadata":419,"author":420,"categories":422,"relatedPosts":427},"En baisse de 9 % par rapport à son plus haut niveau historique, l'action Stryker peut-elle offrir de nouveaux rendements en 2026 ?","2026-03-04 10:55:00","La forte dynamique du Mako et la croissance robuste du MedSurg sont à l'origine des perspectives de Stryker. L'action pourrait atteindre 503 $ d'ici 2028, ce qui représente une hausse de 30 % par rapport aux niveaux actuels.",1262,"\u002Fblog\u002Fdown-9-from-all-time-high-can-stryker-nyse-stock-deliver-further-returns-in-2026","down-9-from-all-time-high-can-stryker-nyse-stock-deliver-further-returns-in-2026","images\u002FSYK-stock\u002FSYK-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772517855\u002Fimages\u002FSYK-stock\u002FSYK-stock.png?_i=AA",{"altText":411},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":421},[],[423],{"name":424,"slug":425,"uri":426,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":429,"date":412,"excerpt":430,"wordCount":414,"uri":431,"slug":432,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":433,"featuredImageMetadata":434,"author":435,"categories":437,"relatedPosts":439},"En hausse de 54 % au cours des 12 derniers mois, l'action Analog Devices peut-elle continuer sur sa lancée en 2026 ?","L'action d'Analog Devices a bondi de 56 % en 12 mois grâce à la demande d'infrastructures d'IA. Cette dynamique peut-elle se poursuivre ? Nous analysons l'objectif de cours de 422 $ d'ADI et son potentiel de hausse de 20 %.","\u002Fblog\u002Fup-56-in-last-12-months-can-analog-devices-nyse-adi-stock-continue-its-strong-run-in-2026","up-56-in-last-12-months-can-analog-devices-nyse-adi-stock-continue-its-strong-run-in-2026","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F03\u002FADI-stock-600x400.png",{"altText":429},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":436},[],[438],{"name":424,"slug":425,"uri":426,"description":243,"postsCount":255},[],{"id":255,"title":441,"date":442,"excerpt":443,"wordCount":444,"uri":445,"slug":446,"cloudinaryAssetId":447,"featuredImageOriginalUrl":448,"featuredImageMetadata":449,"author":450,"categories":452,"relatedPosts":454},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":441},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":451},[],[453],{"name":424,"slug":425,"uri":426,"description":243,"postsCount":255},[],{"id":255,"title":456,"date":382,"excerpt":457,"wordCount":458,"uri":459,"slug":460,"cloudinaryAssetId":461,"featuredImageOriginalUrl":462,"featuredImageMetadata":463,"author":464,"categories":466,"relatedPosts":468},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27 % à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":456},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":465},[],[467],{"name":424,"slug":425,"uri":426,"description":243,"postsCount":255},[],{"id":255,"title":470,"date":471,"excerpt":472,"wordCount":473,"uri":474,"slug":475,"cloudinaryAssetId":476,"featuredImageOriginalUrl":477,"featuredImageMetadata":478,"author":479,"categories":481,"relatedPosts":483},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":470},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":480},[],[482],{"name":424,"slug":425,"uri":426,"description":243,"postsCount":255},[],{"id":255,"title":485,"date":412,"excerpt":486,"wordCount":487,"uri":488,"slug":489,"cloudinaryAssetId":490,"featuredImageOriginalUrl":491,"featuredImageMetadata":492,"author":493,"categories":495,"relatedPosts":500},"Pourquoi l'action d'AeroVironment a chuté de plus de 20 % cette semaine","AeroVironment plonge de 19 % après la réouverture par l'armée de l'espace d'un contrat SCAR d'une valeur de 1,4 milliard de dollars. Raymond James rétrograde l'action de \"strong buy\" à \"underperform\".",799,"\u002Fblog\u002Fwhy-aerovironment-avav-stock-tanked-over-20-this-week","why-aerovironment-avav-stock-tanked-over-20-this-week","images\u002FAVAV-stock_955099f985\u002FAVAV-stock_955099f985","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772536085\u002Fimages\u002FAVAV-stock_955099f985\u002FAVAV-stock_955099f985.png?_i=AA",{"altText":485},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":494},[],[496],{"name":497,"slug":498,"uri":499,"description":243,"postsCount":255},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[]]